QLT Settles Visudyne Royalty Spat For $20M
Pharmaceutical firm QLT Inc. has reached a $20 million settlement with Massachusetts General Hospital, putting to rest a royalty dispute related to sales of an eye treatment....To view the full article, register now.
Already a subscriber? Click here to view full article